Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 19694630)

1.

Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.

Amsterdam JD, Wang G, Shults J.

Acta Psychiatr Scand. 2010 Mar;121(3):201-8. doi: 10.1111/j.1600-0447.2009.01462.x. Epub 2009 Aug 19.

PMID:
19694630
2.

Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium.

Loch AA, Zanetti MV, de Sousa RT, Chaim TM, Serpa MH, Gattaz WF, Teixeira AL, Machado-Vieira R.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jan 2;56:243-6. doi: 10.1016/j.pnpbp.2014.09.014. Epub 2014 Oct 5.

PMID:
25290636
3.
4.

Early improvement with lithium in classic mania and its association with later response.

Machado-Vieira R, Luckenbaugh DA, Soeiro-de-Souza MG, Marca G, Henter ID, Busnello JV, Gattaz WF, Zarate CA Jr.

J Affect Disord. 2013 Jan 10;144(1-2):160-4. doi: 10.1016/j.jad.2012.05.039. Epub 2012 Aug 17.

5.

Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.

Alevizos B, Alevizos E, Leonardou A, Zervas I.

Psychiatriki. 2012 Apr-Jun;23(2):143-8.

PMID:
22796912
6.

Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study.

Li Z, Qi D, Chen J, Zhang C, Yi Z, Yuan C, Wang Z, Hong W, Yu S, Cui D, Fang Y.

Psychoneuroendocrinology. 2013 Jan;38(1):107-14. doi: 10.1016/j.psyneuen.2012.05.005. Epub 2012 Jun 7.

PMID:
22683211
7.

Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: a retrospective analysis.

Barak Y, Swartz M, Baruch Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1744-7. doi: 10.1016/j.pnpbp.2011.06.007. Epub 2011 Jun 24.

PMID:
21722691
8.

Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study.

de Sousa RT, van de Bilt MT, Diniz BS, Ladeira RB, Portela LV, Souza DO, Forlenza OV, Gattaz WF, Machado-Vieira R.

Neurosci Lett. 2011 Apr 20;494(1):54-6. doi: 10.1016/j.neulet.2011.02.054. Epub 2011 Mar 6.

PMID:
21362460
9.
10.

Functional gastrointestinal disorders: Venlafaxine is a potential therapy for functional chest pain.

Eslick GD, Fass R.

Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):14-6. doi: 10.1038/nrgastro.2010.209. No abstract available.

PMID:
21212774
11.

Combination of lithium and duloxetine in 2 depressed patients refractory to duloxetine monotherapy.

Steffenhagen N, Kürstein B, Kirkby KC, Himmerich H.

Pharmacopsychiatry. 2011 Mar;44(2):72-4. doi: 10.1055/s-0030-1268418. Epub 2010 Dec 15. No abstract available.

PMID:
21161884
12.

Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.

Amsterdam JD, Shults J.

J Clin Psychopharmacol. 2010 Jun;30(3):306-11. doi: 10.1097/JCP.0b013e3181da5300.

13.

Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.

Lobello KW, Preskorn SH, Guico-Pabia CJ, Jiang Q, Paul J, Nichols AI, Patroneva A, Ninan PT.

J Clin Psychiatry. 2010 Nov;71(11):1482-7. doi: 10.4088/JCP.08m04773blu. Epub 2010 Apr 6.

PMID:
20441720
14.

Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.

Masi G, Perugi G, Millepiedi S, Mucci M, Pfanner C, Berloffa S, Pari C, Gagliano A, D'Amico F, Akiskal HS.

Psychiatry Res. 2010 May 15;177(1-2):192-8. doi: 10.1016/j.psychres.2009.01.022. Epub 2010 Apr 8.

PMID:
20381170
15.

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH; EMBOLDEN II (Trial D1447C00134) Investigators.

J Clin Psychiatry. 2010 Feb;71(2):163-74. doi: 10.4088/JCP.08m04942gre. Epub 2010 Jan 26.

PMID:
20122366
16.

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.

Bowden CL, Mosolov S, Hranov L, Chen E, Habil H, Kongsakon R, Manfredi R, Lin HN.

Int Clin Psychopharmacol. 2010 Mar;25(2):60-7. doi: 10.1097/YIC.0b013e328333ac1b.

PMID:
20101186
17.

[Open randomized comparative twelve-week study of lithium and valproate in manic episode].

Mosolov SN, Kostiukova EG, Kapiletti SG, Belen'kaia DV, Shafarenko AA, Fedotov DD.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(11):47-52. Russian.

PMID:
20032954
18.

Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial.

Bobo WV, Epstein RA, Shelton RC.

Hum Psychopharmacol. 2010 Jan;25(1):30-6. doi: 10.1002/hup.1082.

PMID:
20029794
19.

[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].

Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.

Encephale. 2009 Dec;35(6):595-604. doi: 10.1016/j.encep.2009.10.011. Epub . French.

PMID:
20004291
20.

Mania associated with antidepressant treatment: comprehensive meta-analytic review.

Tondo L, Vázquez G, Baldessarini RJ.

Acta Psychiatr Scand. 2010 Jun;121(6):404-14. doi: 10.1111/j.1600-0447.2009.01514.x. Epub 2009 Dec 2. Review.

PMID:
19958306
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk